Collegium Pharmaceutical Inc (NAS:COLL)
$ 31.68 0.1 (0.32%) Market Cap: 1.04 Bil Enterprise Value: 1.35 Bil PE Ratio: 13.15 PB Ratio: 4.66 GF Score: 73/100

Q3 2022 Collegium Pharmaceutical Inc Earnings Call Transcript

Nov 03, 2022 / 08:30PM GMT
Release Date Price: $18.03 (+2.27%)
Operator

Greetings, and welcome to the Collegium Pharmaceutical Third Quarter 2022 Earnings Conference Call. (Operator Instructions)

I will now turn the call over to Dawn Schottlandt at Argot Partners. Thank you. You may begin.

Dawn Schottlandt;Argot Partners

Welcome to Collegium Pharmaceutical's Third Quarter 2022 Earnings Conference Call. I am joined today by Joe Ciaffoni, Collegium's Chief Executive Officer; Colleen Tupper, Chief Financial Officer; and Scott Dreyer, Chief Commercial Officer.

Before we begin today's call, I want to remind participants that none of the information presented today is intended to be promotional and that any forward-looking statements made today are pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. You are cautioned that such forward-looking statements involve risks and uncertainties, including and without limitation, the risks that we may not be able to derive the expected benefits of the acquisition of BioDelivery Sciences International, on the proposed schedule

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot